iSpecimen Inc. (ISPC)

NASDAQ: ISPC · Real-Time Price · USD

1.540

-0.060 (-3.75%)

At close: Aug 28, 2026, 4:00 PM EDT

1.532

-0.008 (-0.54%)

After-hours: Aug 28, 2026, 7:56 PM EDT

-3.75% (1D)

Market Cap	3.88M -5.4%
Revenue (ttm)	466,302 -92.1%
Net Income	-11.42M
EPS	-21.95
Shares Out	2.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	88,471
Open	1.580
Previous Close	1.600
Day's Range	1.510 - 1.610
52-Week Range	1.400 - 127.200
Beta	1.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About ISPC

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company’s marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, naso... [Read more]

Industry Diagnostics & Research

Sector Healthcare

IPO Date Jun 17, 2021

Employees 7

Stock Exchange NASDAQ

Ticker Symbol ISPC

Website https://ispecimen.com

Full Company Profile

Financial Performance

In 2025, iSpecimen's revenue was $1.93 million, a decrease of -79.24% compared to the previous year's $9.29 million. Losses were -$10.49 million, -16.09% less than in 2024.

Financial Statements